Latest Articles

Publication Date
GSK enters Indian oncology market with gynaecological cancer drugs - MSN

GSK enters Indian oncology market with gynaecological cancer drugs MSN

Published: Aug. 28, 2025, 8:16 a.m.
Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure - The Times of India

Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure The Times of India

Published: Aug. 27, 2025, 8:16 a.m.
Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure - Times of India

Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure Times of India

Published: Aug. 27, 2025, 1 a.m.
Don’t normalise period pain: Endometriosis cases rising in India - Times of India

Don’t normalise period pain: Endometriosis cases rising in India Times of India

Published: Aug. 27, 2025, 12:30 a.m.
Don’t normalise period pain: Endometriosis cases rising in India - The Times of India

Don’t normalise period pain: Endometriosis cases rising in India The Times of India

Published: Aug. 27, 2025, 12:30 a.m.
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? - MSN

Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? MSN

Published: Aug. 26, 2025, 12:50 p.m.
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? - Business Today

Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio? Business Today

Published: Aug. 26, 2025, 12:29 p.m.
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare

GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare

Published: Aug. 26, 2025, 8:55 a.m.
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare World

GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare World

Published: Aug. 26, 2025, 8:55 a.m.
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor - connectedtoindia.com

GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor connectedtoindia.com

Published: Aug. 26, 2025, 4:39 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!